Arcturus Therapeutics Holdings Inc. (ARCT)
Nasdaq: ARCT · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2019
Filings
253 filings since 2017 beside 163 insider forms · Accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextAccelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.
Filings a yearinsider forms included
5081495660514029
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest May 7, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Apr 5, 2024.A late-filing notice, Form NT 10-Q, filed Nov 12, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jul 2, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jun 26, 2026
May 7, 2026
8-K items 2.02, 5.02, 7.01, 9.01
Results released; Officer or director change; Investor disclosure (Regulation FD) · Current report
May 1, 2026
Oct 22, 2025
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
40 of 253 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.